The Social Determinants of Health Screening and Referral Project

May 2, 2025 updated by: Margaret Parker, University of Massachusetts, Worcester

Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care Unit

Up to a quarter of the families with preterm infants have unmet social needs, such as housing or job insecurity, which represent adverse social determinants of health (SDOH). Preterm infants are especially vulnerable to the social conditions they grow up in, with sustained impacts on function across multiple organ systems. The goal of this study is to translate an established model of SDOH screening and referral from the outpatient setting to the NICU, thereby maximizing the potential to offset the effects of adverse SDOH on vulnerable mother-preterm infant dyads.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

The goal of this study is to implement SDOH screening and referral models in 7 safety net NICUs, examining their potential to offset the effects of adverse SDOH for a highly vulnerable population at the earliest stages of life. The investigators propose a hybrid effectiveness-implementation stepped wedge cluster randomized trial using the Proctor Conceptual Model of Implementation Research. The investigators will follow a cohort of 882 mother-infant dyads longitudinally for 12 months after NICU discharge to examine family, maternal, and infant outcomes. Each site will participate in three phases: usual, experimental, and sustainment.

The study aims are to:

Aim 1: Examine the implementation of SDOH screening and referral models into the NICU (acceptability, feasibility, penetration, equity, and sustainability).

Aim 2: Examine the effectiveness and equity of SDOH screening and referral models in the NICU setting on parental receipt of community resources for unmet social needs 3 months post-NICU discharge.

Aim 3: Explore the effectiveness of SDOH screening and referral models in the NICU to improve (a) maternal mental health (depression) and (b) health and developmental outcomes of preterm infants (quality of life, growth, development, and respiratory disease) during the 12 months post-NICU discharge.

Study Type

Interventional

Enrollment (Estimated)

882

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80204
        • Denver Health Hospital Authority
    • Florida
      • Jacksonville, Florida, United States, 32209
        • Shands Jacksonville Medical Center, Inc. DBA UF Health Jacksonville
    • Michigan
      • Detroit, Michigan, United States, 48201
        • Children's Hospital of Michigan
    • Mississippi
      • Jackson, Mississippi, United States, 39216
        • University of Mississippi Medical Center
    • New York
      • Bronx, New York, United States, 10467
        • Children's Hospital at Montefiore
    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19140
        • Temple University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infant gestational age <34 weeks' gestation; singleton or multiple.
  • Infant hospitalized for at least 14 days of life (to allow for SDOH screening/referral and contact with resources if applicable).
  • Mother and infant are alive.
  • Mother speaks and reads English or Spanish.
  • Infant will be discharged home from the NICU (to allow for follow-up).
  • Mother will care for her infant(s) at home in the US for at least 12 months after discharge from the NICU.

Exclusion Criteria:

  • Mothers or infants who die before anticipated infant discharge.
  • Infant discharged after 52 weeks postmenstrual age.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Social needs screening and referral care
As a step wedge cluster randomized trial all sites will be assigned to receive the intervention in a randomized order. There is no difference in the intervention by site, the only difference is the timing of the beginning of the intervention. Therefore, we have only identified one arm.
WE CARE is a relatively simple, low-intensity intervention that has two key components: (1) screening individuals using the WE CARE SDOH Screener for unmet social needs, and (2) providing individuals who have unmet social needs with SDOH Community Resource sheets
Other Names:
  • WE CARE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Penetration of SDOH intervention
Time Frame: Monthly for approximately 12 months
Penetration is the rate of administration of social needs screener and appropriate referral for community resources to eligible families.
Monthly for approximately 12 months
Receipt of ANY Community Resource
Time Frame: 3 months Post-NICU discharge
Receipt of any community resource as collected via participant survey specifying receipt of the resource.
3 months Post-NICU discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustainability of SDOH intervention
Time Frame: Monthly for approximately 6 months.
Number of individuals who continued to get screened after active intervention is complete.
Monthly for approximately 6 months.
Equity of implementation
Time Frame: Monthly for approximately 18 months (during both penetration and sustainability).
Penetration rate by maternal demographics.
Monthly for approximately 18 months (during both penetration and sustainability).
Equity of receipt of community resources
Time Frame: 3 months Post-NICU discharge
Rate of receipt of community resources by maternal demographics
3 months Post-NICU discharge
SDOH Risk
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Any social need or change in social need for housing, food, utilities, childcare, employment, transportation, or education was collected via participant survey.
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
SDOH Desire Assistance
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Any desired assistance or change in desired assistance for housing, food, utilities, childcare, employment, transportation, and education was collected via participant survey.
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
SDOH Community Resource
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Number of individuals who received any community resource (housing, food, utilities, education, employment, childcare, transportation).
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Maternal Wellbeing
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Rating of current overall health
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Postpartum maternal primary care utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of appointments with a primary care provider
3 months, 6 months, and 12 months Post-NICU discharge
Maternal Postpartum Obstetric Care Utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of appointments with a maternal postpartum obstetric provider
3 months, 6 months, and 12 months Post-NICU discharge
Maternal emergency room utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of emergency room visits.
3 months, 6 months, and 12 months Post-NICU discharge
Maternal hospital readmission
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of overnight hospital readmissions
3 months, 6 months, and 12 months Post-NICU discharge
Maternal Depression
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Overall score on Personal Health Questionnaire Depression Scale (PHQ8), an 8-item instrument with 4 category Likert scale responses from 0 to 4 where 0=not at all and 4=daily. Scores can range from 0 to 32. Higher scores are associated with greater levels of maternal depression.
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Length of Lactation
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Duration of milk production in months
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Infant primary care utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of appointments with a primary care provider
3 months, 6 months, and 12 months Post-NICU discharge
Infant utilization of emergency care
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of emergency room visits
3 months, 6 months, and 12 months Post-NICU discharge
Infant hospital readmission
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Number of overnight hospital readmissions
3 months, 6 months, and 12 months Post-NICU discharge
Receipt of necessary infant services and equipment
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
The proportion of individuals who receive services and equipment among those individuals who indicate needing services and equipment on the national survey of children with special healthcare needs
3 months, 6 months, and 12 months Post-NICU discharge
Infant Respiratory Symptoms (shortness of breath, wheezing, coughing, clinically demonstrated need for oral corticosteroids)
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Overall score on Test for Respiratory and Asthma Control in Kids. Each item is scored from 0 to 20 points on a 5-point Likert-type scale for a total score ranging from 0 to 100. Higher scores indicate better respiratory control.
3 months, 6 months, and 12 months Post-NICU discharge
Infant growth
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Weight for age z-score change
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
Infant Quality of Life
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
Overall score on the Infant Toddler Quality of Life Questionnaire™ (ITQOL) is a 47-item short form that is scored on a scale from 0 (worst health) to 100 (best health). Higher scores indicate a better quality of life.
3 months, 6 months, and 12 months Post-NICU discharge
Acceptability of SDOH intervention
Time Frame: Approximately 7, 9, and 12 months
Mean score on Acceptability of Intervention Measure (AIM), which is a 4-item measure of perceived intervention acceptability. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). The score is calculated mean, and higher scores are associated with better acceptability. (Minimum score is 4, maximum score is 20).
Approximately 7, 9, and 12 months
Feasibility of SDOH intervention
Time Frame: Approximately 7, 9, and 12 months.
Mean score on Feasibility of Intervention Measure (FIM) is A 4-item instrument to assess perceived intervention feasibility. Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree). Score is calculated mean, and higher scores are associated with better feasibility. (Minimum score is 4, maximum score is 20).
Approximately 7, 9, and 12 months.
Family Economic Pressure
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
The Family Economic Pressure scale is a 2-item measure that is scored and summed together. Scores on Measures A and B are from the Economic Pressure Scale. Higher levels indicate higher economic hardship. (Minimum score is 6, maximum score is 30).
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Margaret Parker, MD, MPH, University of Massachusetts Chan Medical School
  • Principal Investigator: Mari-Lynn Drainoni, PhD, MEd, Boston University Chobanian and Avedisian School of Medicine
  • Principal Investigator: Arvin Garg, MD, MPH, University of Massachusetts Chan Medical School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2024

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

August 14, 2024

First Submitted That Met QC Criteria

August 29, 2024

First Posted (Actual)

September 3, 2024

Study Record Updates

Last Update Posted (Actual)

May 7, 2025

Last Update Submitted That Met QC Criteria

May 2, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data requests can be submitted to the MPIs after study completion.

IPD Sharing Time Frame

Data requests can be submitted to the MPIs 6 months after study completion.

IPD Sharing Access Criteria

Access to data can be requested by qualified researchers engaging in independent scientific research. Requests must include review and approval of the research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Statement (DSA).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Implementation of social determinants of health screening and referral

Subscribe